4th Quarter - Report

F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES

Period 4th Quarter 2008 Filed Jan 15, 2009 Signed by Evan Morris, Vice President Federal Government Affairs and Public Policy

Official filing
Firm
F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
Client
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES
Income
—
Expenses
$1,171,453
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Housing HOU

Issues related to Federal position on mold testing.

LobbyistCovered position, as disclosed
THOMAS BARNETT Director, Diagnostics
BRUCE THOMAS TAYLOR Director, Diagnostics

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Transportation, Dept of (DOT); Agriculture, Dept of (USDA); SENATE; Labor, Dept of (DOL); Treasury, Dept of

Health Issues HCR

Pandemic preparedness, Accutane safety, Federal government's purchasing and stockpiling of Tamiflu; H.R. 1283/S. 626, The Arthritis Prevention, Control and Cure Act of 2008; S.2029, Physician Payments; Sunshine Act of 2007, pertaining to disclosing pharmaceutical payment so physicians; monitor general health care issues and support for organization's products; diabetes issues with OMB and federal issues with Indiana delegation; healthcare appropriations

LobbyistCovered position, as disclosed
DARIN GARDNER Director of Federal Government Affairs
JOYCE IRWIN New Director, Diagnostics (Government Affairs)
EVAN MORRIS Vice President of Federal Government Affairs
JAMES SCOTT Director of Federal Government Affairs

Contacted: Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Treasury, Dept of; SENATE; Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Transportation, Dept of (DOT)

Bills named: S. 2029 (110th), H.R. 1283 (110th), S. 626 (110th)

Medicare/Medicaid MMM

Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment requiring cancer drugs; Medicare coding policies for Part B drugs; S.2499 Medicare, Medicaid and SCHIP Extension Act of 2007 - Issues related to Medicare coverage policy for blood glucose monitors and test strips; issues related to dynamic scoring.

LobbyistCovered position, as disclosed
THOMAS BARNETT Director, Diagnostics
KATHLEEN A CLAESSENS Director, Diagnostics
DARIN GARDNER Director of Federal Government Affairs
JAMES SCOTT Director of Federal Government Affairs
BRUCE THOMAS TAYLOR Director, Diagnostics

Contacted: Treasury, Dept of; Agriculture, Dept of (USDA); Transportation, Dept of (DOT); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE; Labor, Dept of (DOL); Health & Human Services, Dept of (HHS)

Bills named: S. 2499 (110th)

Budget/Appropriations BUD

Federal lobbying Issues related to government purchases of pandemic drugs, Tamiflu and taxes

LobbyistCovered position, as disclosed
DARIN GARDNER Director of Federal Government Affairs
JAMES SCOTT Director of Federal Government Affairs

Contacted: Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE; Labor, Dept of (DOL); Agriculture, Dept of (USDA); Transportation, Dept of (DOT)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.